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Abstract
Background: Phage-display panning is an integral part of biomedical research. Regular panning
methods are sometimes complicated by inefficient detachment of the captured phages from the
antigen-coated solid supports, which prompted us to modify. Here, we produce an efficient
antigen-specific single chain fragment variable (scFv) antibody by using a target-related molecule
that favored selection ofrecombinant antibodies.
Results: To produce more selective and specific anti-idiotypic scFv-antibodies from a cDNA
library, constructed from HM-1 killer toxin (HM-1)-neutralizing monoclonal antibodies (nmAb-
KT), the method was modified by using an elution buffer supplemented with HM-1 that shares
structural and functional similarities with the active site of the scFv antibody. Competitive binding
of HM-1 to nmAb-KT allowed easy and quick dissociation of scFv-displayed phages from
immobilized nmAb-KT to select specific anti-idiotypic scFv antibodies of HM-1. After modified
panning, 80% clones (40/50) showed several times higher binding affinity to nmAb-KT than regular
panning. The major populations (48%) of these clones (scFv K1) were genotypically same and had
strong cytocidal activity against Saccharomyces and Candida species. The scFv K1 (Kd value = 4.62 ×
10-8 M) had strong reactivity toward nmAb-KT, like HM-1 (Kd value = 6.74 × 10-9 M) as judged by
SPR analysis.
Conclusion: The scFv antibodies generated after modified subtractive panning appear to have
superior binding properties and cytocidal activity than regular panning. A simple modification of the
elution condition in the phage-display panning protocol makes a large difference in determining
success. Our method offers an attractive platform to discover potential therapeutic candidates.
Background
Fungal infections have recently emerged as a growing
threat to human health, especially in persons whose
immune systems are compromised [1]. Nowadays, the
most common treatment for fungal infections is based on
the use of amphotericin B, 5-flucytosine and fluconazole.
However, these drugs have repeatedly failed against infec-
tions caused by Candida and Cryptococcus species [2]. A
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series of antigenic peptides from fungal pathogens have
been identified that can generate immune responses, and
which may assist in developing an antifungal vaccine
[3,4]. Therefore, development of novel molecules and
alternative therapeutic strategies for the battle against fun-
gal infections is becoming a topical and widely recognized
need. To combat against fungal diseases, we are trying to
produce a single, but general, antifungal vaccine by using
an improved and optimized phage-display panning
method that elicits immune responses in immunocom-
promised individuals who are at risk of invasive fungal
infections by opportunistic fungal pathogens, as well as
other multiple fungal infections.
One of the most widely used library methods is based on
the use of a filamentous phage, a virus that lives on
Escherichia coli. Using a phage-display system, various
antibody fragments can be displayed on the surface of fil-
amentous phages containing the antibody gene as a
phagemid [5-8]. However, antibody fragments, including
single chain fragment variable (scFv) molecules, have
been developed for potential clinical applications [9].
Production of recombinant antibodies using phage-dis-
play technology has many advantages over conventional
polyclonal and monoclonal antibody production [10-12].
Phage-display technology and antibody engineering have
been used to isolate scFvs that can interact with a wide
variety of antigens [13,14]. An effective and reliable
method is needed to produce antibodies with high anti-
genic specificity and affinity. In this study, we investigated
the de novo selection of DNA that encodes scFvs specific
to the immunogen, HM-1 killer toxin (HM-1)-neutraliz-
ing monoclonal antibodies (nmAb-KT) from splenocytes
of a hyper-immunized mouse.
Conventional methods of phage-display panning immo-
bilize purified antigen to plates or other solid supports to
which libraries are applied, and then use extensive wash-
ings in detergent-supplemented buffers to select specific
phage antibodies [15]. These methods sometimes are not
so effective due to tight antigen-antibody binding and
attachment to the solid support of the tubes or plates. To
optimize the method of phage-display panning and also
to recover high-affinity anti-idiotypic phage antibodies
from immobilized antigens, different elution conditions
have been used [16,17]. Each antigen-antibody interac-
tion requires careful fine-tuning of elution conditions to
produce antigen-specific scFv antibodies [17,18]. We are
trying to establish an improved, optimized subtractive
panning method to select antigen-specific antibodies
more efficiently.
Killer toxins are protein molecules that disrupt cell func-
tions in a number of ways, some by making ion channels
in cell membranes and others by interacting with mem-
brane channels or receptors or both [19,20]. Among yeast
killer toxins, HM-1 is highly stable against heat treatment
and a wide range of pH values (pH 2 to 11) and also
exhibits the wide spectrum of anti-microbial activity [21-
24]. These unique properties of this toxin have made it
attractive for therapeutic applications, but not for clinical
use because of their instability in the host physiological
conditions as well as their antigenicity. To overcome the
intrinsic toxicity and chemical instability of HM-1, more-
over taking advantage of its immunogenicity, nmAb-KT
has been produced. To produce a new anti-fungal drug,
previously we used nmAb-KT as an immunogen in mice to
get an antigen-specific recombinant anti-idiotypic scFv
antibody, sharing structural or functional or both similar-
ities with the active site of HM-1 [3]. In this study, selec-
tion of phage-displayed scFv was based on specific antigen
nmAb-KT coated on to immunotubes and that was chosen
to explore the potential of the cDNA library, constructed
from nmAb-KT, to isolate antigen-specific antibody frag-
ments. The strategy applied for the modified subtractive
panning, tested within five cycles, was based on the
premise that competitive binding of HM-1 to coated
nmAb-KT can improve selection efficiency by an easy and
quick dissociation of scFv-displayed phages from the
immobilized surface. The ultimate goal of this study was
to produce recombinant antibodies and to characterize
their properties by immunoassay parameters, DNA analy-
sis, product stability and functionality.
Results
Selection of clones with improved characteristics
Solid phase panning as described by Griffiths et al. [7] was
used to select nmAb-KT-specific phage scFv. Selection of
phages with specificity for nmAb-KT was based on increas-
ing stringency of selection at each round of panning (Fig-
ure 1). Enrichment was determined to check the number
of phages recaptured after each round of panning by
counting the colony forming units (CFU) of the infected
E. coli TG1. The phage-display library consisted of 2.8 ×
1010 clones (CFU/ml) with a final diversity of 3.4 × 105
separate clones after fifth round of modified subtractive
panning. Figure 2 showed the phage recovery after each
round of regular panning and modified subtractive pan-
ning. Transformed E. coli TG1 cells in which the amber
stop codon between the E-tag DNA sequence and g3 gene
is read through, allowing the production of the scFv-E tag-
g3 fusion protein. In the presence of helper phage
M13KO7, scFv fusion products were displayed on the
recombinant phage tips, allowing affinity selection. In the
regular panning method, small differences were in the
stringency of selection between different rounds of pan-
ning, but in modified subtractive panning after two or
three rounds of selection, the antigen-binding clones
showed a clear enrichment (Figure 2). In modified sub-
tractive panning, the stringency of panning was signifi-BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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cantly increased after the fourth and fifth rounds of
panning. During different selection rounds of modified
subtractive panning, bound scFv-containing phages were
eluted easily and quickly from the immobilized nmAb-KT
by using an elution buffer supplemented with HM-1 at
concentration 10 μg/ml. The phage enrichment for regu-
lar panning was not as impressive as for modified subtrac-
tive panning. For regular panning, the number of
recaptured phages increased approximately 2-fold with
low binding affinity in every round, but in modified sub-
tractive panning, the number of recaptured phages
increased 3 - 5 fold in the first three rounds of panning but
increased 10-fold in the fourth and fifth rounds with
higher binding strength to the antigen (Figure 2). Thus,
the overall enrichment for modified subtractive panning
was approximately 10-fold higher than for regular pan-
ning after the final fifth round of panning (Figure 2).
To verify the panning performance, we identified antigen-
specific positive clones binding to the immobilized
Schematic representation of the phage-display selection procedure: modified subtractive panning Figure 1
Schematic representation of the phage-display selection procedure: modified subtractive panning. Phage parti-
cles displaying the members of the library were produced. The specific binder (nmAb-KT) was allowed to bind with the target, 
and other variants were removed by washing. Molecular variants with specificity for the target were retrieved after multiple 
cycles of selection and were characterized in detail. Bound phages were eluted with HM-1 containing phosphate buffer (pH 
7.0). HM-1 had high binding affinity to the immobilized nmAb-KT. This competition of binding favored quick dissociation of 
scFv-containing phages from the bound nmAb-KT and consequently increased the elution stringency of the infected phages.BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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nmAb-KT antigen. The binding properties of 50 randomly
selected clones binding to nmAb-KT for both types of pan-
ning were measured by using microtiter plate enzyme-
linked immunosorbent assay (ELISA). The supernatant
containing soluble scFv antibodies was added to each well
of a microtiter plate that had been pre-coated with nmAb-
KT, and detection was done by using horseradish peroxi-
dase (HRP)-conjugated anti-E-tag antiboy. For regular
panning, 24% (12 of 50) tested clones of the infected E.
coli TG1 contained the anti-idiotypic scFv gene of HM-1
killer toxin, and so soluble scFv showed positive ELISA
signals after the fifth round of panning (Figure 3A and
Table 1). Interestingly, for modified subtractive panning,
80% (40 of 50) tested clones showed positive ELISA sig-
nal, also after the fifth round of panning with higher bind-
ing strength to nmAb-KT (Figure 3B and Table 2). Positive
binding affinity was defined as an absorbance for immo-
bilized nmAb-KT that was 2-fold above the background or
negative controls. Negative controls consisted of micro-
titer plates coated with blocking buffer (N-1) or washing
buffer (N-2).
To examine the integrity of the library after the final
rounds of modified subtractive panning, 50 individual
colonies in E. coli TG1 were randomly isolated and the
presence of the scFv DNA insert in these clones was con-
firmed by using polymerase chain reaction (PCR) ampli-
fication; these amplified products were analyzed on 4%
agarose gels (Figure 4A). Among these 50 colonies, 40
Enrichment of phage-displayed scFvs by panning Figure 2
Enrichment of phage-displayed scFvs by panning. Phage-displayed scFvs were selected against nmAb-KT and were rein-
fected into E. coli TG1. The number of phages eluted after each round of panning was counted based on the number of colonies 
(CFU/ml) formed after reinfection of the eluted phage particles in the host bacteria. The results were means of triplicates.
Table 1: Panning results of the phage-displayed library
Antigen Panning type Rounds Positives*
nmAb-KT Regular panning 5 12/50, 24%
nmAb-KT Modified subtractive panning 5 40/50, 80%
* Randomly selected clones were grown overnight and supernatants 
were tested for binding to the immobilized antigen by ELISA.BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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were positive. Only five restriction patterns were identi-
fied by the agarose gel electrophoresis; these patterns were
confirmed by sequence data analysis. Among these five
restriction patterns, four patterns contained inserts of the
expected size (780 bp) fragments and the other pattern
contained a low molecular weight DNA (540 bp) frag-
ment (Figure 4B).
Sequence analysis of scFv clones
At least five unique genes (K1 - K5) were identified by
nucleotide sequencing after the fifth round of modified
subtractive panning. Table 2 showed the percentages of
positive clones based on identical DNA sequences.
Among all positive clones, K1 (19/40, 48%) and K2 (15/
40, 38%) were identified as the highest populated group
of clones after successful screening. Among the other pos-
itive clones, K3 was 10% (4/40) and K4 and K5 were each
only 2%. Figure 5 showed amino acid sequences deduced
from the obtained nucleotide data. All five sequences had
different amino acid substitutions that were expected and
mostly were in complementarity determining regions
(CDR) [25]. The light chains of all clones were slightly dif-
ferent from each other, except scFv K2. For scFv K2, a light
chain variable domain was partially synthesized together
with an E-tag sequence. In the CDR area, the amino acid
sequences shared relatively low sequence homology.
Apparently, the degree of homology was observed higher
in the variable region of the light chain (VL) domain com-
pared with the variable region of the heavy chain (VH)
domain. K1 and K4 differed by only one amino acid at
position 93 in the VH domain.
Production and characterization of nmAb-KT-specific scFv
All 40 individual positive clones after E. coli TG1 infection
were reinfected into E. coli HB2151. In the nonsuppressor
strain of E. coli HB2151, the amber stop codon between E-
tag and g3 fusion protein was recognized as a stop codon,
and a soluble scFv-E tag fusion protein was produced as a
consequence. The expression of the scFv-E-tag fusion pro-
tein in the resultant E. coli HB2151 clones was induced by
isopropyl β-D-thiogalactopyranoside (IPTG), and soluble
scFv antibodies were secreted into the culture superna-
tants. After the final fifth round of modified subtractive
panning, 80% clones (40/50) were positive with a strong
binding affinity to nmAb-KT (Figure 3B). However, in reg-
ular panning after the fifth round of panning only 24%
(12/50) were positive clones with low binding affinity
(Figure 3A). The nmAb-KT-binding pattern of soluble scFv
antibodies from these 40 positive clones of E. coli HB2151
was almost similar to that of the parent phage E. coli TG1
scFv antibodies, which was confirmed by using ELISA
(Additional file 1, Figure S1). After screening, clones scFv
K1 - K5 were identified, and soluble scFvs were purified
from the periplasmic extract of E. coli HB2151 on an anti-
E-tag affinity column.
SDS-PAGE and Western blotting to check scFv expression
The culture supernatant without anti-E-tag column purifi-
cation, an approximately 30 kDa (expected molecular
weight (MW)) and two types of small (MW 20 kDa and 16
kDa) scFv-E tag fusion protein were expressed from the
reinfected E. coli HB2151 (Figure 6A). There expressions
indicated that all 40 positive clones originated from our
original cDNA library constructed by pCANTAB 5 E vector
using the E-tag sequence. Four clones of purified soluble
scFv (K1, K3, K4 and K5) showed two strong protein
bands (30 kDa and 16 kDa) by using sodium dodecyl sul-
phate-polyacrylamide gel electrophoresis (SDS-PAGE)
and by Western blot analysis with HRP-conjugated anti-E-
tag antibody (Figures 6B, C). Both proteins contained E-
tag sequences, so Western blotting using HRP-conjugated
anti-E-tag antibody detected bands. For the short
sequenced scFv K2 clone, a 20 kDa E-tagged protein band
showed before purification (Figure 6A), but after anti-E-
tag column purification a protein band was not detected
by using SDS-PAGE and Western blotting (Figures 6B, C).
Functional characterization and antifungal activity of 
recombinant scFvs
In vitro antifungal activity of recombinant scFv antibodies
was examined for non-pathogenic and pathogenic strains
of fungal species Saccharomyces cerevisiae and Candida albi-
cans, respectively. First, in vitro susceptibility of S. cerevisiae
to scFv antibodies was examined by cell suspension assay
as described in the Materials and Methods (Figure 7A).
Among all scFv antibodies, scFv K1 was the most effective
antifungal agent. Figure 7B showed the elution profile and
biological activity of purified scFv K1 against the growth
of S. cerevisiae A451. Next, to check the candidacidal activ-
ity of scFv K1 antibodies against C. albicans ATCC 10231,
Table 2: Percentages of positive clones based on distinct DNA sequences after the fifth round of modified subtractive panning
Clone type No. of clones with identical sequence % of distinct DNA sequences
K1 19/40 48
K2 15/40 38
K3 4/40 10
K4 1/40 2
K5 1/40 2BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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Identification of positive clones to immobilized antigen Figure 3
Identification of positive clones to immobilized antigen. The binding properties of randomly selected clones to nmAb-
KT were measured by microtiter plate ELISA. The supernatant containing soluble scFv antibodies was added to each well of a 
microtiter plate that had been pre-coated with nmAb-KT and detection was done by HRP-conjugated anti-E-tag antibody. A. 
Regular panning: 12 of 50 (24%) tested clones of infected E. coli TG1 contained the anti-idiotypic scFv gene of HM-1 killer 
toxin, and so soluble scFvs showed positive ELISA signals after the fifth round of panning. B. Modified subtractive panning: 
40 of 50 (80%) tested clones showed positive ELISA signals after the fifth round of modified subtractive panning. Negative con-
trols consisted of microtiter plates coated with blocking buffer (N-1) or washing buffer (N-2). The results were means of dupli-
cates.BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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DNA fingerprint analysis of specific scFv genes of positive clones Figure 4
DNA fingerprint analysis of specific scFv genes of positive clones. scFv inserts were amplified from individual colonies 
of all positive clones. Amplification was done with Ex-Taq DNA polymearase enzyme using pCANTAB5-R1 and pCANTAB5-
S6 primers. The amplified products were then analyzed on agarose gels. A. scFv encoding inserts of DNA of 40 diversified pos-
itive clones B. Only five restriction patterns of scFv encoding inserts of DNA were identified against five different clones (scFv 
K1 - K5). Molecular weights of DNA ladder markers (kbp) were indicated by M on the left.BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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cell growth was also measured by cell suspension assay
(Figure 7C). Table 3 showed the IC50 values of scFv K1
against S. cerevisiae A451 and C. albicans ATCC 10231 cells
growth in vitro. Extensive studies by using our assay system
showed that 2.20 × 10-6 M and 3.83 × 10-6 M were suffi-
cient to produce 50% inhibition of growth of S. cerevisiae
A451 and C. albicans ATCC 10231, respectively.
Kinetic parameters of selected clone scFv K1
The binding specificities and kinetic parameters of puri-
fied scFv K1, HM-1 and HYI killer toxin (HYI) were deter-
mined by using surface plasmon resonance (SPR)
analysis. Biacore sensograms showed the degree of inter-
action between immobilized nmAb-KT and scFv K1, HM-
1 or HYI (figure not shown). Kinetic data from SPR anal-
ysis showed that scFv K1 had a strong binding affinity for
nmAb-KT, like HM-1, but HYI had no binding affinity for
nmAb-KT. HM-1 analyte was used for the positive control
and HYI analyte was used for the negative control experi-
ment [26]. Table 4 showed the calculated values of kon,
koff, Ka and Kd. The Kd values of scFv K1 and HM-1 were
4.62 × 10-8 M and 6.74 × 10-9 M, respectively. Therefore,
we can conclude that scFv K1 had strong reactivity with
nmAb-KT, like HM-1, but not with HYI.
Competitive binding of scFv K1 antibody with HM-1 to 
nmAb-KT
To examine whether scFv K1 antibody compete with HM-
1 to bind with nmAb-KT, a competitive binding ELISA was
performed (Figure 8). When the scFv K1 antibody concen-
tration was increased, the binding of scFv K1 antibody to
nmAb-KT was also increased, but the HM-1 binding to
nmAb-KT was simultaneously decreased. These results
suggest that scFv K1 antibody clone was homologous in
competition with HM-1 for binding to nmAb-KT.
Alignment of amino acid sequences of scFv K (1-5) antibody fragments Figure 5
Alignment of amino acid sequences of scFv K (1-5) antibody fragments. Amino acid sequences were deduced from 
the nucleotide sequences. Positions of the respective complementarity determining regions for the variable domains of heavy 
chain (CDR H1-3) and light chain (CDR L1-3) were indicated by bold symbols. Framework (Fw) and CDRs as defined by Kabat 
et al. [44] were indicated. (Fw 1 - 4) were framework parts of antibody domains. To compare with scFv K1, amino acid differ-
ences in the other four clones were shown by gray symbols.BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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SDS-PAGE and Western blot analysis of scFv expression Figure 6
SDS-PAGE and Western blot analysis of scFv expression. A. Supernatant containing the soluble scFv antibodies for 40 
diversified positive clones underwent SDS-PAGE and then Western blotting. B. Molecular weights of purified soluble scFv anti-
bodies (K1 - K5) were detected by SDS-PAGE and were stained with silver stain. C. Western blotting of duplicate SDS-poly-
acrylamide gels was detected by probing with HRP-conjugated anti E-tag antibody. Molecular weights of marker proteins (kDa) 
were indicated by M on the left.BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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Discussion
Anti-idiotypic antibodies representing the internal image
of some antigenic determinants have been proposed as
surrogate vaccines [3,27], and antibodies conjugated with
toxins have been proposed for immunotherapy of cancer
[28]. In some cases, amino acid sequence homology exists
between the protein antigen and the anti-idiotypic anti-
body variable region [29]. Antigenic mimicry is usually
more functional than biochemical, and the functional
mimicry of ligands of biological receptors by anti-idio-
typic antibodies has been extensively studied [26,30]. To
select a useful and specific scFv antibody for a target anti-
Table 3: IC50 values for the recombinant scFv K1 anti-idiotypic 
antibody against the cell growth of Saccharomyces and Candida 
species*
IC50 (× 10-6 M) for:
Antibody C. albicans ATCC 10231 S. cerevisiae A451
scFv K1 3.83 2.20
*IC50 values for recombinant scFv K1 against cell growth of Candida 
and Saccharomyces species were measured by using a cell suspension 
assay as described in the Methods.
Functional characterization of recombinant scFvs by measuring in vitro antifungal activity Figure 7
Functional characterization of recombinant scFvs by measuring in vitro antifungal activity. A. Biological activity of 
purified five clones scFv (K1 - K5). The effect of recombinant scFvs on the growth of S. cerevisiae A451 cells was measured by a 
cell suspension assay as described in Methods. Gray bars: Yeast Growth (%); black bars: Protein at 280 nm. B. Elution profile 
for scFv purification by using an anti-E-tag Sepharose column and the biological activity of the selected clone (scFv K1) against 
the growth of S. cerevisiae A451. Purified scFv K1 proteins per fraction (fr) were detected and visualized by SDS-PAGE and 
Western blotting with HRP-antiE-tag conjugate. A clear band of the expected size (30 kDa) for E-tag containing scFv was 
present in the purified elution fractions. C. Biological activity of scFv K1 against C. albicans ATCC 10231. For all cases fungal 
growth was measured at 600 nm. The results were means of duplicates.BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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gen, a high quality primary phage library is needed [31].
Importantly, the library must have a large functional size
to match diverse antibody sequences to facilitate the selec-
tion of a variety of high affinity scFvs, and these scFv genes
must be well expressed to allow the panning process. Pre-
viously, we established a large mouse scFv phage display
library (2.8 × 1010 CFU/ml), and we attempted to isolate
antigen-specific scFvs by using nmAb-KT as a model anti-
gen [32]. In this study, after proper selection of the library,
phage-displaying anti-idiotypic scFv antibodies repre-
sented the internal image of the original antigen HM-1
and thus might be effective as a vaccine, avoiding immu-
nization with a pathogen.
For traditional panning procedures, elution conditions
are not same to recover a wide variety of specific phages
from the immobilized antigens. Sometimes bound
phages are not easily dissociated from the immobilized
antigen because of tight antigen-antibody interaction and
attachment with the solid support of the tubes or plates.
Table 4: Kinetic parameters for binding of scFv K1, HM-1 and HYI to nmAb-KT measured by SPR analysis
Ligand Analytes kon (× 104 M-1 s-1) koff (× 10-4 s-1) Ka (× 107 M-1) Kd (× 10-8 M)
nmAb-KT scFv K1 1.02 4.71 2.17 4.62
nmAb-KT HM-1 4.92 3.31 14.80 0.674
nmAb-KT HYI ND ND ND ND
Ligand nmAb-KT was immobilized on the surface of a CM5 sensor chip, and scFv K1, HM-1 peptide or HYI peptide, were then injected over this 
immobilized surface in the presence of HBS-EP buffer. The affinity constant (Ka) and dissociation constant (Kd) were obtained from the ratio of the 
association (kon) and dissociation (koff) rate constants derived from global fits of response against time data to a 1:1 Langmuir binding model. Ka = 
kon/koff; Kd = koff/kon; ND, signals not detected. HM-1 analyte was used for the positive control and HYI analyte was used for the negative control 
experiment [26].
Competitive binding analysis of the ability of HM-1 to inhibit the binding of scFv K1 antibody to nmAb-KT Figure 8
Competitive binding analysis of the ability of HM-1 to inhibit the binding of scFv K1 antibody to nmAb-KT. 
ELISA plates coated with nmAb-KT was incubated with increasing concentrations of the selected scFv K1 antibody as 
described in Methods. The results were means of duplicates.BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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Several methods have been reported to improve these
problems to recover phage-displayed scFvs with the high-
est affinity, and some of these methods are applicable to
the selection of anti-idiotypic antibodies [13,18,33-35].
Several elution methods that include the common acidic
or basic conditions have been used to increase the strin-
gency of selection [11,18]. More acidic or basic conditions
sometimes may disrupt the phage particles, and hence
scFvs may lose or change its functional characteristics. So,
we were proceeding an alternative way that will be more
susceptible to get a high affinity binders to the specific
antigen. Therefore, during elution of the bound phages in
modified subtractive panning, we selected neutral phos-
phate-buffered saline (PBS) solution (pH 7.0) supple-
mented with HM-1 that shared structural or functional
similarities with the active site of phage-displayed scFv
antibodies. As a result, elution with HM-1 facilitates and
favors the panning process through competition of bind-
ing to immobilized nmAb-KT (Figure 1). This competi-
tion of binding accelerated the quick dissociation of scFv-
containing phages from the immobilized antigen nmAb-
KT with increased binding strength. The binding strength
and specificity were analyzed by using ELISA with scFv
antibodies against nmAb-KT. Figures 3A and 3B compared
the bindings between antigen nmAb-KT and scFv antibod-
ies obtained after using regular and modified subtractive
pannings. The ELISA signals with soluble scFv antibodies
from modified subtractive panning were much stronger
than those from regular panning, indicating that the bind-
ing strength improved for elution with HM-1 in the selec-
tion procedure.
For further confirmation of the binding specificity of
phage-displayed scFvs to antigen nmAb-KT after each
round of panning, the number of recaptured phages was
quantified. Figure 2 clearly demonstrated that after each
round of panning the recaptured phages for modified sub-
tractive panning were markedly higher than those for reg-
ular panning. Although the regular panning experiments
were successful, they failed to enrich the phage clones suf-
ficiently may be because of less dissociation of tightly
bound scFv-containing phages from the solid support of
the tubes or plates during selection.
To ascertain the scFv repertoire and the quality of the
immunized antibody library, DNA segments encoding the
scFv genes from 40 randomly selected positive clones
(80%; 40/50) were identified after the fifth round of mod-
ified subtractive panning (Figure 3B). However, after the
fifth round of regular phage display panning only 24%
clones (12/50) were positive but with low binding affinity
(Figure 3A). The 40 positive clones that had higher bind-
ing affinity were amplified by using the polymerase chain
reaction (PCR), and the amplified products were analyzed
on agarose gels and their DNA fingerprint patterns were
compared (Figure 4A). The patterns of these clones were
found to vary, indicating an excellent diversity in the
immunized mouse scFv library. Nucleotide sequencing
showed that at least five unique scFv genes were identified
by using modified subtractive panning, i.e., clones scFv
K1- scFv K5 were analyzed to deduce the amino acid
sequences (Figure 5). DNA sequencing also confirmed
that the highest population of the positive clones (48%,
19/40) was unique (scFv K1) with a higher binding
strength to the antigen nmAb-KT. Also, the second highest
populated group scFv K2 (38%, 15/40) had short DNA
sequences in the VL domain compared with the other
groups. DNA fingerprints of K1 and K3 - 5 were appar-
ently identical (Figure 4B), although their amino acid
sequences differed. Therefore, we produced at least five
different anti-idiotypic scFv antibody clones of HM-1.
The scFvs, carrying the E-tag sequence and fused to the C-
terminus, were purified by using an anti-E-tag affinity col-
umn and were analyzed on SDS-PAGE followed by West-
ern blotting performed against HRP/anti-E tag conjugate.
Silver-stained gel analysis of all purified scFvs showed a
sharp, unique band (except scFv K2) of the expected MW
of 30 kDa together with an unexpected band of lower MW
(16 kDa); these bands were detected by Western blotting
with the HRP/anti-E-tag conjugate (Figures 6B, C). The
low MW 16 kDa bands had the E-tag sequence detected by
Western blotting, indicating that they might be proteolytic
cleavage derivatives of the original 30 kDa scFvs. Interest-
ingly, scFv K2 expressed a 20 kDa smaller protein that also
contained an E-tag sequence detected by Western blotting
before column purification of the sample (Figure 6A).
This 20 kDa scFv K2 had a partial VL region of the anti-
body, i.e., a residue of 16 amino acids instead of 99 amino
acids that was confirmed from the DNA sequence data
(Figure 5). This 20 kDa scFv K2 represented prematurely
terminated translation products because of mutation.
Purification of scFv K2 by using an anti-E-tag column was
not possible to confirm by SDS-PAGE and Western blot-
ting (Figures 6B, C). Therefore, the E-tag containing short
scFv K2 (20 kDa) passed through the purification column
without binding to the resin of the column that might be
because of conformational changes due to partial lack of
a light chain (VL) domain and might be because of cross-
linking with other parts of the scFv antibody and therefore
not having the open arm for binding with the antiE-tag
sequence of the purification column.
scFv K1 that had the highest population (48%) of positive
clones showed strong cytocidal activity against S. cerevisiae
and Candida species compared with other scFvs (Figures
7A, B &7C). So, for further experiments we selected scFv
K1 to characterize the functional activity and specificity.
In this study, the antifungal activity was evaluated by cell
suspension assay as described in the Materials and Meth-BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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ods. The scFv K1 antibody showed strong antifungal activ-
ity against S. cerevisiae and C. albicans in vitro with IC50
values 2.20 × 10-6 M for S. cerevisiae A451 and 3.83 × 10-6
M for C. albicans ATCC 10231. The anti-idiotypic scFv K1
had high affinities as judged by SPR. BIAcore analysis
indicated Kd = 4.62 × 10-8 M for scFv K1, which was com-
parable to the HM-1 killer toxin (Kd = 6.74 × 10-9 M).
Therefore, we concluded that nmAb-KT showed strong
reactivity toward scFv K1, like HM-1, but not toward HYI.
Furthermore, the binding of scFv K1 antibody to nmAb-
KT was competitive with that of HM-1 (Figure 8), i.e.,
equimolar concentration of HM-1 inhibited the binding
of scFv K1 antibody to the immobilized nmAb-KT anti-
gen. Based on several factors, such as expression level,
ELISA using nmAb-KT, BIAcore (Kd = 4.62 × 10-8 M) and
fungal killing activity, scFv K1 was considered the most
desirable scFv. So, scFv K1 is a candidate for future studies
directed at killing of pathogenic fungal species using an
scFv-drug conjugate or by development into a whole IgG
format for complement-mediated and antibody-depend-
ent cytotoxic pathways.
Conclusions
In conclusion, we successfully obtained recombinant scFv
antibodies with high specificity against nmAb-KT directly
from the phage-displayed scFv library of a hyper-immu-
nized mouse. Filamentous phage-displaying scFvs were
selected against nmAb-KT and were enriched through five
rounds of modified subtractive panning. The scFv anti-
bodies generated after modified subtractive panning
appear to have superior binding properties than for regu-
lar panning. We showed a simple modification of the elu-
tion condition in the phage-display panning protocol,
and so make a large difference in determining success. The
deduced amino acid sequences of CDRs might also help
us to create other scFv fragments with even higher affinity
and specificity for nmAb-KT and fungal cells by further
mutagenesis study.
Methods
Bacterial and fungal strains
E. coli TG1 amber suppressor strain was used as the bacte-
rial host to prepare phagemids and as the host for bacteri-
ophage M13KO7. E. coli HB2151 non-suppressor strain
was used to express soluble scFvs. S. cerevisiae A451 and C.
albicans ATCC 10231 were a kind gift from Nippon Roche
Research Center.
Antigens, antibodies and conjugates
HM-1 was extracted from the broth culture of yeast Willi-
opsis saturnus var. mrakii IFO 0895 and was purified as
described previously [36,37]. HYI was prepared in our
laboratory as previously described [38]. The purified
nmAb-KT was prepared at the Technology Incubation &
Transfer Ltd. (Saitama, Japan). M13KO7 helper phage,
HRP-anti-E tag conjugate and an anti-E-tag Sepharose col-
umn were obtained from GE Healthcare UK Ltd., UK.
Phage-displayed scFv library construction and phage 
rescue
HM-1-like anti-idiotypic scFv antibodies used in this
study were produced according to the procedure of the
Recombinant Phage Antibody System (GE Healthcare UK
Ltd., UK.). Previously, a large mouse scFv phage display
library 2.8 × 1010 (CFU/ml) was constructed in our labo-
ratory according to the manufacturer's protocol using a
mouse scFv module and an expression module. Briefly,
DNA fragments encoding VH and VL were amplified from
reverse-transcribed mRNA by using PCR and were fused
by a DNA fragment encoding a linker peptide. The assem-
bled scFv fragments were ligated into the phagemid vector
pCANTAB 5 E and then were transformed into competent
E. coli TG1 cells so that the phage-displayed antibodies
can be panned on immobilized antigen. Recombinant
phages produced in E. coli TG1 were repeatedly panned
against nmAb-KT and were screened by using conven-
tional ELISA with nmAb-KT. The library was rescued by
infection with helper phage M13KO7 for the next round
of panning. The library size was calculated by counting
the number of ampicillin-resistant colonies. Library qual-
ity was verified by determining the percentage of clones
with inserts of appropriate size for a scFv gene. The diver-
sity of the library was confirmed by sequencing randomly
selected clones.
Library selection on immunotubes against antigen nmAb-
KT
A. Regular panning
The phage repertoire was panned by affinity selection
using immunotubes (Nunc; Maxisorp) coated with anti-
gen nmAb-KT [7,11]. The tubes were coated with nmAb-
KT by incubating them overnight at concentration 10 μg/
ml in PBS (pH 7.0) at 4°C. A large mouse scFv phage-dis-
play library containing 2.8 × 1010 clones (CFU/ml) was
used for the selection. The library stock was grown in log
phase, was rescued with M13KO7 helper phage and was
amplified overnight in 2× YT-AK (10 g bacto-yeast extract,
17 g bacto-tryptone, 5 g NaCl per litre of water (2× YT)
containing 100 μg/ml ampicillin and 50 μg/ml kanamy-
cin) at 37°C on a shaker. The phage was precipitated with
4% polyethylene glycol/0.5 M NaCl, was resuspended in
2× YT medium and was incubated with blocking buffer of
PBS containing 4% skimmed milk at room temperature
for 15 min to block nonspecific binding. After three times
rinsing with PBS, phage particles were added to the immu-
notubes and were incubated on a shaker at 37°C for 2 h.
After this incubation, unbound and nonspecifically
bound scFv-phages of the tubes were washed away by rins-
ing the immunotubes 20 times with PBST (PBS contain-
ing 0.05% Tween 20) and then another 20 times withBMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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PBS. The bound phage particles were then immediately
used to infect exponentially growing E. coli TG1 cells (OD
at 600 nm = 0.5) for 1 h at 37°C. After each round of pan-
ning the infected cells were mixed with 10% glycerol and
were then stored at -80°C. For the next round of panning,
3 ml of infected E. coli TG1 cell stock was added to 50 ml
of 2× YT-AG (2× YT containing 100 μg/ml ampicillin and
2% glucose) medium and was grown to log phase. The
culture was rescued with M13KO7 helper phage, was
amplified, was precipitated, and was used for the next
round of selection. Regular phage display panning was
repeated five times as described above. The phage output
from the final fifth round selection was propagated and
50 randomly selected E. coli TG1 colonies underwent
ELISA.
B. Modified subtractive panning
To produce more effective antigen-specific recombinant
anti-idiotypic scFv antibodies of HM-1 with superior
binding strength to antigen nmAb-KT, a modified subtrac-
tive panning strategy was used for all five rounds of pan-
ning in the subsequent phage display experiment. The
panning procedure was the same as the regular panning,
except that an additional incubation step with HM-1 was
added in each round of selection. To increase the elution
stringency of the bound scFv-phages from the immobi-
lized surface (nmAb-KT) of the tube, 10 μg/ml of HM-1 in
PBS (pH 7.0) solution was added and was incubated at
37°C with a rotator shaker for 1 h. Specifically bound
scFv-phages were eluted from the immobilized nmAb-KT
and after the final fifth round of panning, the phages out-
put were propagated, and 50 randomly selected E. coli
TG1 colonies were selected for screening.
Expression and purification of soluble scFvs
Soluble scFv fragments specific for the nmAb-KT antigen
were produced by transfecting phages from positive
clones identified by competitive ELISA into E. coli
HB2151. This strain of E. coli recognizes the amber stop
codon between the scFv and the gene III fragment. The
procedures for infecting E. coli HB2151 cells and produc-
tion of soluble antibodies were described in detail in the
expression module of the recombinant phage antibody
system (GE Healthcare UK Ltd., U.K.). Expression and
periplasmic extraction of scFv were done as described by
Yau et al. [12]. IPTG (1 mM) was used to induce scFv in
exponentially growing cells (OD at 600 nm = 0.5) for 12
- 16 h at 30°C. The expressed products from whole cell
extracts, supernatants, and periplasmic extracts of the spe-
cific colonies were analyzed to determine the location of
accumulation of soluble antibodies. Recombinant soluble
scFv antibodies were produced from the periplasmic
extract of E. coli HB2151 cells, which were purified by
using affinity chromatography with an anti-E-tag Sepha-
rose column (Hi-Trap anti-E-tag column) according to the
manufacturer's protocol. The concentration was deter-
mined spectrophotometrically at A280 nm 1.0 correspond-
ing to 0.5 mg/ml scFv.
ELISA screening of clones
Soluble scFv-based ELISA was done for screening. For
both types of panning after the fifth round of selection,
phages were rescued from single ampicillin-resistant colo-
nies of infected E. coli TG1 cells [11,39]. The relative affin-
ity and specificity of soluble scFvs were assessed against
the antigen nmAb-KT as described by Clackson et al. [5].
Briefly, 96-well plates were coated with 10 μg/ml nmAb-
KT in PBS overnight at 4°C, and were blocked with PBS
containing 4% skimmed milk powder. Approximately 50
μl per well of soluble scFv supernatant from the overnight
cell culture was added, was incubated for 2 h at room tem-
perature and then was washed three times with PBST. The
bound scFvs were detected by incubation with 8000-fold
diluted of HRP-conjugated anti-E-tag antibody (GE
Healthcare UK Ltd., U.K.) for 1 h at room temperature.
The wells were washed again three times with PBST and
50 μl of 0.022% 2',2'-azino-bis(3-ethylbenzthiazoline-6-
sulfonic acid [ABTS]/H2O2 substrate solution was added
to each well by using citric acid. The absorption was meas-
ured at 405 nm.
Fingerprint analysis of scFv genes and DNA sequencing
After the fifth round of modified subtractive panning, the
diversity of selected scFv clones was analyzed by finger-
print analysis of the scFv genes of the positive clones. Plas-
mid DNAs from anti-idiotypic antibody producing clones
were isolated from E. coli HB2151 by alkaline lysis and the
scFv gene insert of individual clones was amplified by
using PCR with pCANTAB5-R1 primer (5'-CCATGAT-
TACGCCAAGCTTTGGAGCC-3') and pCANTAB5-S6
primer (5'-GTAAATGAATTTTCTGTATGAGG-3') and with
Ex-Taq DNA polymerase enzyme (Takara). The amplified
products were analyzed on agarose gels. The amplified VH
and VL DNA portions in the plasmids were sequenced by
using a CEQ 2000XL-DNA Analysis System with Dye Ter-
minator Cycle Sequencing Quick Start Kit (BECKMAN
COULTER, Inc.). The sequence alignment and manipula-
tion were performed by using DNASIS program (Hitachi
Corp.), and also the sequences were compared by using
The Kabat Database system [40].
SDS-PAGE and Western blotting
SDS-PAGE analysis was done as described by Laemmli
U.K. [41]. Proteins were separated on 15% acrylamide
gels, followed by staining of silver nitrate or Western blot-
ting. For Western blotting, the purified periplasmic frac-
tion of E. coli HB2151 culture underwent SDS-PAGE and
was blotted on to a polyvinylidene fluoride membrane by
using a semi-dry electroblotter. After blocking with 4%
skimmed milk, the separated proteins were detected byBMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99
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HRP-conjugated anti-E-tag monoclonal antibody using Ez
West Blue dye for HRP (Atto Corporation, Tokyo, Japan).
A broad range pre-stained protein marker was used as a
molecular weight marker.
In vitro antifungal activity of anti-idiotypic scFv antibodies
A qualitative antifungal assay of purified scFv antibodies
was done by using a cell suspension assay as described by
Komiyama et al. [42]. Briefly, purified scFv antibodies
were passed through an anti-E-tag Sepharose column at
various concentrations in 80 μl of 20 mM glycine HCl,
were neutralized with sodium phosphate buffer (pH 7.0),
was mixed with 160 μl of YPD (1.0% bacto-yeast extract,
2.0% bacto-peptone and 2.0% glucose) medium contain-
ing 3 × 103 cells/ml of S. cerevisiae A451 and was incu-
bated with gentle shaking at 30°C for 16 - 18 h. Glycine
HCl neutralized with sodium phosphate buffer (pH 7.0)
was used as a control. To measure the IC50 value, the con-
centration requiring 50% inhibition, different concentra-
tions (10 - 80 μg/ml) of selected clone scFv K1 antibody
was added to inhibit cell growth. The IC50 values were
evaluated from semi-logarithmic graphs. To measure the
biological activity against C. albicans ATCC 10231, the
same procedure as described above was used, except the
Candida concentration was 500 cells/ml.
Affinity determination of selected scFv fragments by SPR 
analysis
The scFv K1 fragments, HM-1 (positive control) and HYI
(negative control) were selected for determination of
affinity to antigen nmAb-KT [26]. The binding kinetics of
scFv K1 to immobilized antigen nmAb-KT were measured
by using SPR analysis with a BIAcore × (BIAcore Uppasala,
Sweden) according to the manufacturer's instructions. For
the BIAcore experiments, nmAb-KT (30 μg/ml) was cova-
lently immobilized on CM5 sensor chips using an amine
coupling kit as described previously by Gruen et al. [43].
In this experiment, HBS-EP buffer (10 mM HEPES, 150
mM NaCl, 3 mM EDTA, 0.005% polysorbate 20 (pH 7.4))
was used, as the eluent buffer at a flow rate of 10 μl/min.
The surface of the sensor chip was regenerated by pulse
injection of 10 μl of 100 mM HCl (pH 1.2). The binding
data were analyzed with the 1:1 Langmuir binding model
in the BIAevaluation software (BIAcore).
Competitive binding of scFv K1 antibody with HM-1 to 
nmAb-KT
ELISA plate was coated with 10 μg/ml of nmAb-KT and
blocked with 4% skimmed milk powder in PBS solution
for 1 h at 37°C. The scFv K1 antibody was applied in
ratios of 1:1 to 1:50, followed by the addition of fifty
microliters of HM-1 (50 ng/ml) as a competitor. Binding
of scFv K1 was detected by HRP-conjugated anti-E tag
antibody. Binding of HM-1 was also detected with anti-
HM-1 rabbit serum followed by HRP-conjugated anti-rab-
bit IgG antibody (Promega, USA). Using ABTS-diammo-
nium salt in citric acid, the absorption was measured at
405 nm.
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